All India Institute of Medical Sciences (AIIMS) is reportedly developing some specific guidelines to treat the black fungus disease also known as mucormycosis, according to the news agency ANI.
Cases of mucormycosis have been reported in several places of the country, specifically in states like Maharashtra, Gujarat, Karnataka, Uttarakhand, Telangana, Odisha, Madhya Pradesh, and Bihar. Mucormycosis or black fungus is a complication caused by a fungal infection, according to the Union Health Ministry. Due to exposure to the COVID-19 virus, this fungal disease is rapidly spreading.
As stated by the doctors, it is caused by a set of micro-organisms known as mucormycetes, which are present naturally in the environment. These are seen mostly in soil and in decaying organic matter like leaves, compost, and piles.
People can catch mucormycosis by coming in contact with the fungal spores in the environment. The fungus can also develop on the skin after it somehow enters the skin through a cut, scrape, burn, or any other type of skin trauma. It stated that the treatment of Covid patients with black fungus involves the intake of drugs like dexamethasone.
The guidelines for the black fungus by AIIMS are yet to be disclosed. However, it will be very important for other medical facilities to contain the disease and treat patients with it.
The disease is currently being detected among patients who are recovering or have recovered from COVID-19. Moreover, anyone who is diabetic and whose immune system is not properly functioning needs to be very cautious against this, said the health ministry.